Back to search
Influenza Immunity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Influenza Immunity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Influenza Immunity trials you may qualify forThis study will investigate the effects of woodsmoke (WS) exposure on human nasal mucosal immune responses to viral infection. The study tests the hypotheses th…
Background: Influenza (flu) is a contagious respiratory illness caused by viruses. Flu symptoms can range from mild to severe, and the illness can be fatal. Va…
This experimental medicine study aims to compare immune responses in healthy adult volunteers aged 18-55 years against influenza vaccination and infection in th…
Background: Respiratory viruses, like the flu or COVID-19, cause significant illness and death worldwide. Researchers want to collect samples from people with…
Background: Influenza (flu) vaccinations are required for all NIH staff members who have direct contact with patients. COVID-19 vaccines are recommended for pe…
This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of its safety and how it builds pr…
This is a single-center, randomized, open-label trial designed to explore the interaction between mucosal microbiota colonization in the nasal cavity and gut an…
Background: The influenza (flu) virus infects millions around the world every year. Children are at increased risk of complications from the flu. The flu vacci…
Background: \- Influenza is a common viral infection, but it can be deadly for some people. Researchers want to learn more about how the body fights this virus…